) and incorporated into these prognostic units, but none of these attempts succeeded in becoming standard of treatment.94–96 In truth, the Intercontinental Workshop on CLL (iwCLL) tips only advise analyzing the IGHV standing and existence/absence of TP53 aberrations in regimen practice.translocations or amplifications in addition to the genomic a